혈액 분석기 시장 규모, 점유율, 성장 분석 : 제품별, 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Hematology Analyzer Market size was valued at USD 2.51 Billion in 2024 and is poised to grow from USD 2.7 Billion in 2025 to USD 4.77 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global hematology analyzer market is experiencing robust growth, driven by the rising incidence of blood disorders and an aging population that is increasingly susceptible to these conditions. Technological advancements are revolutionizing this sector, with the introduction of fully automated analyzers that enhance accuracy, throughput, and user experience. The integration of sophisticated software and data management systems is optimizing laboratory workflows and expediting result reporting. Furthermore, the shift towards point-of-care testing (POCT) is gaining traction, enabling rapid on-site analysis and reducing sample transport needs, which is vital in remote areas. Collectively, these elements are propelling the demand for hematology analyzers and ensuring that the market continues to expand, catering to diverse laboratory needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology Analyzer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Analyzer Market Segments Analysis

Global Hematology Analyzer Market is segmented by Product, Type, End User and region. Based on Product, the market is segmented into Instruments, Reagents & Consumables and Services. Based on Type, the market is segmented into Fully-Automated Hematology Analyzers and Semi-automated Hematology Analyzers. Based on End User, the market is segmented into Hospitals, Clinical Laboratories, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Analyzer Market

The growing prevalence of blood disorders, including conditions like anemia, leukemia, and hemophilia, significantly propels the hematology analyzer market. As healthcare professionals seek precise and efficient methods for diagnosing and monitoring these ailments, the demand for advanced hematology analyzers continues to rise. This heightened focus on effective disease management and the need for reliable diagnostic tools drive innovations within the market, contributing to the development of more sophisticated and user-friendly analyzers. Consequently, as healthcare systems increasingly prioritize these technologies, the market is positioned for substantial growth and expansion, reflecting the critical role that hematology analyzers play in modern medical practice.

Restraints in the Global Hematology Analyzer Market

The substantial initial capital investment needed to purchase hematology analyzers, especially the advanced fully automated systems, presents a significant challenge. This high expense can be a major obstacle, particularly for smaller healthcare facilities and those functioning in resource-limited environments. As a result, the financial burden may restrict access to these essential diagnostic tools, potentially hindering the ability of such institutions to deliver quality healthcare services and accurately diagnose hematological conditions. Consequently, this barrier may limit the overall growth and adoption of hematology analyzers within the global market, impacting both healthcare providers and patient outcomes.

Market Trends of the Global Hematology Analyzer Market

A significant trend in the global hematology analyzer market is the growing embrace of automation and integration within laboratory settings. This trend enhances operational efficiency by facilitating quicker analyses, minimizing human errors, and optimizing overall workflow. Advanced hematology analyzers now feature sophisticated automated capabilities, including sample handling, result interpretation, and comprehensive data management systems, which are increasingly sought after by laboratories. This shift not only fosters greater productivity but also supports the accurate and timely diagnosis of hematological conditions, aligning with the broader healthcare industry's emphasis on precision and efficiency in patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Hematology Analyzer Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Instruments
  • 3 Part Hematology Analyzer
  • 5 Part Hematology Analyzer
  • 6 Part Hematology Analyzer
  • Point-of-care Testing Hematology Analyzers
  • Others
• Reagents & Consumables
• Services

Global Hematology Analyzer Market Size by Type & CAGR (2026-2033)

• Market Overview
• Fully-Automated Hematology Analyzers
• Semi-automated Hematology Analyzers

Global Hematology Analyzer Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinical Laboratories
• Research Institutes
• Others

Global Hematology Analyzer Market Size & CAGR (2026-2033)

• North America (Product & Service, Type, End User)
  • US
  • Canada
• Europe (Product & Service, Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boule Diagnostics AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diatron (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drew Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayto Life and Analytical Sciences Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Partec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HORIBA Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations